豆盟科技(01917.HK)上半年淨虧4700萬元
格隆匯8月27日丨豆盟科技(01917.HK)公佈中期業績,2021年中期,收益總額約為人民幣4840萬元,較2020年中期上升約39.3%。收益總額上升主要由於相較於2020年中期,國內COVID-19疫情的管理受控,客户逐步復工復產,廣吿投入數量、節奏及預算有所恢復。
2021年中期,集團的公司擁有人應占虧損及其他全面收益為人民幣4700萬元,2020年中期則為人民幣2860萬元。每股基本虧損為人民幣0.021元(2020年中期:人民幣0.012元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.